MEDIVIR A/S: Financial statements 2013
CVR: 30587014
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
MEDIVIR A/S (CVR 30587014) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 106,507 and a net result of DKK 555,479 compared with DKK 611,175 the year before. That is a decrease of 14.8% compared with the year before. Equity in the 2013 report amounted to DKK 8,734,085. The solvency ratio was 19,568.2%.
- Gross Profit
- DKK 106,507
- Profit/Loss
- DKK 555,479
- Equity
- DKK 8,734,085
- Total Assets
- DKK 44,634
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 107 t. | 555 t. | 8.7 mio. | - |
| 2012 | - | 125 t. | 611 t. | 8.2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
On September 1, 2013, the company changed its name from BIOPHAUSIA A/S to MEDIVIR A/S.
MEDIVIR A/S has published its annual report for 2012. Gross profit came to DKK 125,051, and the net result was DKK 611,175.
About MEDIVIR A/S
MEDIVIR A/S was a Danish company of the type Aktieselskab based in Herlev, founded in 2007. The company has been dissolved on 11 May 2016. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named BIOPHAUSIA A/S and GFKJURA 986 A/S. The company has 0 employees (2012). In 2014, the company reported a gross profit of DKK -113,058 and a net result of DKK -539,466 compared with DKK 555,479 the year before. Equity in the 2014 report amounted to DKK -9,273,551.